Valuation: Viatris Inc.

Market Cap 19.56B 17.13B 15.78B 14.65B 27.82B 1,866B 28.19B 189B 73.52B 916B 73.47B 71.86B 3,176B P/E 2026 *
61.5x
P/E 2027 * 26.6x
Enterprise Value 31.75B 27.81B 25.61B 23.77B 45.15B 3,029B 45.76B 307B 119B 1,487B 119B 117B 5,154B EV / Sales 2026 *
2.15x
EV / Sales 2027 * 2.03x
Free-Float
92.23%
Yield 2026 *
3.03%
Yield 2027 * 3.11%
1 day+0.60%
1 week+3.51%
Current month+5.79%
1 month+5.79%
3 months+25.28%
6 months+35.48%
Current year+34.94%
1 week 15.92
Extreme 15.92
16.98
1 month 14.94
Extreme 14.94
16.98
Current year 12.19
Extreme 12.19
17.53
1 year 8.62
Extreme 8.625
17.53
3 years 6.85
Extreme 6.85
17.53
5 years 6.85
Extreme 6.85
17.53
10 years 6.85
Extreme 6.85
50.4
Manager TitleAgeSince
Chief Executive Officer 63 2023-03-31
Director of Finance/CFO 59 2026-05-07
Chief Administrative Officer 42 2025-08-18
Director TitleAgeSince
Chairman 58 2023-12-14
Director/Board Member 70 2020-11-15
Director/Board Member 78 2020-11-15
Date Insider Type Main position Quantity % Market Cap.
06-29Free

Director

2,362 0.0002%
06-29Free

Director

2,756 0.0002%
06-24Sell

Chief Financial Officer

-50,076 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
+0.60%+3.51%+80.26%+70.73% 19.56B
-1.14%-2.43%+53.72%+159.07% 1,070B
-1.41%+0.32%+66.23%+60.48% 624B
-2.42%+0.18%+34.59%+85.62% 450B
-0.26%+0.53%+31.00%+25.82% 328B
-2.46%-1.38%+36.42%+36.52% 292B
-2.20%-0.87%+27.50%+42.69% 284B
-1.77%+1.97%-28.85%-40.66% 217B
-2.06%+1.63%+22.87%+64.34% 198B
-1.26%+2.60%+15.98%+70.00% 161B
Average -1.44%+1.32%+33.97%+57.46% 364.39B
Weighted average by Cap. -1.54%+0.79%+39.91%+80.77%

Financials

2026 *2027 *
Net sales 14.77B 12.94B 11.92B 11.06B 21.01B 1,409B 21.29B 143B 55.52B 692B 55.48B 54.27B 2,398B 15.04B 13.17B 12.13B 11.26B 21.38B 1,434B 21.67B 145B 56.51B 704B 56.47B 55.23B 2,441B
Net income 13M 11.38M 10.48M 9.73M 18.48M 1.24B 18.73M 126M 48.84M 609M 48.81M 47.74M 2.11B 498M 436M 401M 373M 707M 47.46B 717M 4.8B 1.87B 23.3B 1.87B 1.83B 80.77B
Net Debt 12.19B 10.67B 9.83B 9.12B 17.33B 1,162B 17.56B 118B 45.8B 571B 45.77B 44.76B 1,978B 11.03B 9.66B 8.9B 8.26B 15.68B 1,052B 15.9B 107B 41.45B 516B 41.42B 40.52B 1,791B
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.
Employees
30,000
Date Price Change Volume
26-07-06 US$16.80 +0.60% 11,422,070
26-07-02 US$16.70 +3.21% 9,042,025
26-07-01 US$16.18 +1.89% 13,488,471
26-06-30 US$15.88 -2.16% 10,545,203
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
16.80USD
Average target price
17.81USD
Spread / Average Target
+6.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VTRS Stock